Tapewire

Nasdaq · USD

HALO

HALOZYME THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
793
SEC CIK
0001159036
Parsed reports
393

Last 12 months

Inside the activity.

0 purchase rows · 106 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025010
Dec 202505
Jan 202601
Feb 202607
Mar 2026010
Apr 202606
May 2026013
Jun 2026011
Jul 202604
Aug 2026012
Sep 2026011
Oct 2026016

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 27,605 $79.44 $2,192,941.20
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 6

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 749,731

F3 · shares: The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.

Read SEC document
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 51,171 $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 777,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 9,104 $79.44 $723,221.76
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 726,165

F2 · shares: The reported disposition of 9,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.

Read SEC document
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 16,875 $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 735,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Tax withholdingCommon Stock 11,334 $79.44 $900,372.96
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 718,394

F1 · shares: The reported disposition of 11,334 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.

Read SEC document
February 16, 2026 Filed Feb 17, 2026 23:51 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 21,009 $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,728

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:21 UTC
Caudill CortneySVP, CHIEF OPERATING OFFICER
GrantPerformance Stock Units · Derivative 14,751 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 4

Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,751

Underlying: Common Stock · 14,751 shares

Expires not disclosed

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:21 UTC
Caudill CortneySVP, CHIEF OPERATING OFFICER
GrantPerformance Stock Units · Derivative 2,403 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 3

Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,886

Underlying: Common Stock · 2,403 shares

Expires not disclosed

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:21 UTC
Caudill CortneySVP, CHIEF OPERATING OFFICER
GrantRestricted Stock Units · Derivative 13,047 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 2

Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,047

Underlying: Common Stock · 13,047 shares

Expires not disclosed

F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:21 UTC
Caudill CortneySVP, CHIEF OPERATING OFFICER
GrantOption to Purchase Common Stock · Derivative 14,047 $0.00 Strike: $80.48 $0.00
Disclosure

SEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 1

Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,047

Underlying: Common Stock · 14,047 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
GrantPerformance Stock Units · Derivative 29,502 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 5

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires not disclosed

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
GrantPerformance Stock Units · Derivative 7,808 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 4

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,127

Underlying: Common Stock · 7,808 shares

Expires not disclosed

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
GrantPerformance Stock Units · Derivative 4,651 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 3

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,016

Underlying: Common Stock · 4,651 shares

Expires not disclosed

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
GrantRestricted Stock Units · Derivative 17,396 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 2

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,396

Underlying: Common Stock · 17,396 shares

Expires not disclosed

F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
GrantOption to Purchase Common Stock · Derivative 18,730 $0.00 Strike: $80.48 $0.00
Disclosure

SEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 1

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,730

Underlying: Common Stock · 18,730 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
GrantPerformance Stock Units · Derivative 29,502 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 3

LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires not disclosed

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
GrantPerformance Stock Units · Derivative 7,448 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 2

LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,045

Underlying: Common Stock · 7,448 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 02:20 UTC
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
GrantPerformance Stock Units · Derivative 5,167 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 1

LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,351

Underlying: Common Stock · 5,167 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 01:56 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantPerformance Stock Units · Derivative 92,714 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,714

Underlying: Common Stock · 92,714 shares

Expires not disclosed

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 01:56 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantPerformance Stock Units · Derivative 24,985 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,400

Underlying: Common Stock · 24,985 shares

Expires not disclosed

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 01:56 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantPerformance Stock Units · Derivative 19,807 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,171

Underlying: Common Stock · 19,807 shares

Expires not disclosed

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 01:56 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantRestricted Stock Units · Derivative 50,013 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,013

Underlying: Common Stock · 50,013 shares

Expires not disclosed

F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.

Read SEC document
February 09, 2026 Filed Feb 12, 2026 01:56 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantOption to Purchase Common Stock · Derivative 53,847 $0.00 Strike: $80.48 $0.00
Disclosure

SEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,847

Underlying: Common Stock · 53,847 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $12.07 Strike: $12.07 $120,700.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 13

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,923

Underlying: Common Stock · 10,000 shares

Expires 2027-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 4,624 $78.94 $365,000.06
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 10

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708,719

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F8 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $78.643 to $79.292. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 5,376 $78.38 $421,365.50
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 9

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 713,343

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F7 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $77.640 to $78.637. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $12.07 $120,700.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 8

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 718,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 20,000 $12.07 Strike: $12.07 $241,400.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 12

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,923

Underlying: Common Stock · 20,000 shares

Expires 2027-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,100 $77.54 $783,154.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 7

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708,719

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F6 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $77.290 to $77.990. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 9,900 $76.94 $761,666.40
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 6

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 718,819

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F5 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $76.275 to $77.260. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 20,000 $12.07 $241,400.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 728,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

Read SEC document
February 03, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 20,000 $12.07 Strike: $12.07 $241,400.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 11

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 231,923

Underlying: Common Stock · 20,000 shares

Expires 2027-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017.

Read SEC document
February 03, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 7,790 $76.73 $597,757.86
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708,719

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $76.490 to $77.030. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 9,659 $75.94 $733,543.10
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 716,509

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $75.470 to $76.460. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 2,551 $74.88 $191,016.33
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 726,168

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $74.450 to $75.442. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2026 Filed Feb 6, 2026 00:38 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 20,000 $12.07 $241,400.00
Disclosure

SEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 728,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 23:55 UTC SaleCommon Stock 2,000 $70.25 $140,500.00
Disclosure

SEC source: 0001159036-26-000006 · wk-form4_1767743752.xml · nonDerivative · entry 1

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,123

F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.

Read SEC document
January 03, 2026 Filed Jan 6, 2026 23:55 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 7,611 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · derivative · entry 3

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,611 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

F2 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

Read SEC document
January 03, 2026 Filed Jan 6, 2026 23:55 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
Tax withholdingCommon Stock 4,243 $70.31 $298,325.33
Disclosure

SEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · nonDerivative · entry 2

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,181

F1 · shares: The reported disposition of 4,243 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.

Read SEC document
January 03, 2026 Filed Jan 6, 2026 23:55 UTC
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 7,611 $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · nonDerivative · entry 1

Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 23:56 UTC GrantOption to Purchase Common Stock · Derivative 1,342 $0.00 Strike: $70.31 $0.00
Disclosure

SEC source: 0001159036-26-000007 · wk-form4_1767743799.xml · derivative · entry 2

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,342

Underlying: Common Stock · 1,342 shares

Expires 2036-01-02

F2 · derivative.exercise_date: Represents a stock options granted under the Issuer director compensation program. This grant will vest in full on the date of the Issuer 2026 annual meeting of stockholders.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 23:56 UTC GrantRestricted Stock Units 889 $0.00 $0.00
Disclosure

SEC source: 0001159036-26-000007 · wk-form4_1767743799.xml · nonDerivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 889

F1 · shares: Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the date of the Issuer's 2026 annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 23:16 UTC
Torley HelenDirector · PRESIDENT AND CEO
GrantPerformance Stock Units · Derivative 165,522 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001159036-25-000073 · wk-form4_1765494963.xml · derivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,522

Underlying: Common Stock · 165,522 shares

Expires not disclosed

F1 · shares: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).

F1 · derivative.exercise_date: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).

F1 · derivative.expiration_date: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:50 UTC SaleCommon Stock 829 $71.60 $59,356.40
Disclosure

SEC source: 0001159036-25-000065 · wk-form4_1764636645.xml · nonDerivative · entry 1

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,123

F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 16,569 $8.11 Strike: $8.11 $134,374.59
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · derivative · entry 7

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,569 shares

Expires 2026-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

F6 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 3, 2016.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 261 $71.60 $18,687.60
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 6

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708,719

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 500 $70.36 $35,181.00
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 708,980

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

F5 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $70.160 to $70.500. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 5,402 $69.44 $375,120.28
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 709,480

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $69.160 to $70.100. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,406 $68.51 $712,935.87
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 714,882

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $68.100 to $69.080. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:31 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 16,569 $8.11 $134,374.59
Disclosure

SEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 725,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.